This course will provide a thorough review of regulatory guidelines on method validation and transfer. It provides guidance on how to perform QC analytical test method validations and transfers.
This course provides guidance on how to perform QC analytical test method validations and transfers. One of the most critical factors in developing and marketing pharmaceutical drug substances and drug products is ensuring that the analytical methods used for analysis can generate valid data upon which business and regulatory decisions can be made. FDA, ICH and USP have each recognized the importance of this relative to the drug development process and have each expanded method validation requirements in recent years. However, with only limited guidance, industry has been left to interpret how to adequately comply with the regulations. This course provides a comprehensive overview of the international regulatory authority requirements and expectations for test method validation of these assays. This course will prepare attendees with the knowledge and tools to plan and execute test method validation packages for the NDA, BLA and MAA market application dossiers, covering in-process, release and stability assays commonly used by QC.
Whether involved in method development, method validation, method verification or method transfer, this course will provide a broad understanding and “hands-on” knowledge of the method validation process and the difficulties encountered in validating methods to comply with today’s upgraded FDA CDER requirements. Lectures will include some of the more common mathematical and statistical treatments of validation data. Because of the tremendous effort that can be expended in conducting validation studies, efficiency of experimental design and documentation will be stressed throughout the discussions. Methods utilized for the analysis of pharmaceuticals generate critical data in the determination of a product’s safety, identity, strength, purity, and quality. It is essential that the quality of the data is assured. Validation is required to demonstrate that these analytical methods are fit for their intended use. The validation data is also required by regulatory agencies for submissions.
This course will provide a thorough review of regulatory guidelines on method validation and transfer. Each element required to have a complete and thorough method validation will be discussed in detail to ensure course attendees have a clear understanding of each requirement.
A review of validation protocol requirements and selection of appropriate acceptance criteria will also occur during the webinar session; as well as, a discussion on how to select suitable statistical calculations for reporting and interpreting the data.
Topic 1: Regulatory Requirements/Guidance on
Topic 2: Analytical Method Pre-Validation – Stage 1
Topic 3: Analytical Method Validation Characteristics – Stage 2
Topic 4: Test Method Validation Protocol
Topic 5: Test Method Validation Report
Topic 6: Regulatory Concerns About Test Method Validations
This course provides guidance on how to perform QC analytical test method validations and transfers. One of the most critical factors in developing and marketing pharmaceutical drug substances and drug products is ensuring that the analytical methods used for analysis can generate valid data upon which business and regulatory decisions can be made. FDA, ICH and USP have each recognized the importance of this relative to the drug development process and have each expanded method validation requirements in recent years. However, with only limited guidance, industry has been left to interpret how to adequately comply with the regulations. This course provides a comprehensive overview of the international regulatory authority requirements and expectations for test method validation of these assays. This course will prepare attendees with the knowledge and tools to plan and execute test method validation packages for the NDA, BLA and MAA market application dossiers, covering in-process, release and stability assays commonly used by QC.
Whether involved in method development, method validation, method verification or method transfer, this course will provide a broad understanding and “hands-on” knowledge of the method validation process and the difficulties encountered in validating methods to comply with today’s upgraded FDA CDER requirements. Lectures will include some of the more common mathematical and statistical treatments of validation data. Because of the tremendous effort that can be expended in conducting validation studies, efficiency of experimental design and documentation will be stressed throughout the discussions. Methods utilized for the analysis of pharmaceuticals generate critical data in the determination of a product’s safety, identity, strength, purity, and quality. It is essential that the quality of the data is assured. Validation is required to demonstrate that these analytical methods are fit for their intended use. The validation data is also required by regulatory agencies for submissions.
This course will provide a thorough review of regulatory guidelines on method validation and transfer. Each element required to have a complete and thorough method validation will be discussed in detail to ensure course attendees have a clear understanding of each requirement.
A review of validation protocol requirements and selection of appropriate acceptance criteria will also occur during the webinar session; as well as, a discussion on how to select suitable statistical calculations for reporting and interpreting the data.
Topic 1: Regulatory Requirements/Guidance on
Topic 2: Analytical Method Pre-Validation – Stage 1
Topic 3: Analytical Method Validation Characteristics – Stage 2
Topic 4: Test Method Validation Protocol
Topic 5: Test Method Validation Report
Topic 6: Regulatory Concerns About Test Method Validations
Kelly Thomas
Ms. Thomas has over two decades of cGMP hands-on industry experience in both pharmaceutical and medical device manufacturing operations. Her experience covers all Quality Systems; as well as, all areas of validation; including, process/product validation, facilities validation, CSV and 21 CFR Part 11, test method validation, equipment/automated processes and cleaning validation.Utilizing strategic thinking, risk based approaches, and Lean principles, she has demonstrated success in steering and managing complex projects within the pharmaceutical and medical device industries.
Treating Employees Like Adults: Discipline versus Empowerme…
7 Ways To Beat Burnout: Without Quitting Your Job
How to Write Procedures to Avoid Human Errors
Ethical Terminations: Navigating Employee Exits with Legal …
Understanding EBITDA – Definition, Formula & Calculation
Handbook Overhaul 2026: Compliance, OBBB Act & Beyond
FDA Proposes Framework to Advance Credibility of AI Models
Project Management for Non-Project Managers - Scheduling yo…
Data Integrity and Privacy: Compliance with 21 CFR Part 11,…
4-Hour Virtual Seminar on Hidden Secrets of Selling & Marke…
Validation Statistics for Non-Statisticians
Work Shouldn’t Feel Like A Soap Opera: Less Drama. More Foc…
Offboarding with Care: Conducting Legal & Ethical Employee …
The Alphabet Soup: When the FMLA, ADA, COBRA, and Workers' …
2-Hour Virtual Seminar on How to Conduct an Internal Harass…
Managing Toxic & Other Employees Who have Attitude Issues
Payments Fraud Detect & Prevent Check, ACH and P-Card Schem…
Reduce Stress in the Workplace: Effective Ways to Handle Co…
Language is Code - Intro to AI - Generative AI - ChatGPT an…
GROUPBY and PIVOTBY functions. Pivot table killers?
How to Prepare for a Regulatory Inspection: FDA, EMA, and N…
Excel - Reporting Simplified - Learn Pivot Tables from Scra…
The Power of Trust: Why It Should Matter to All Leaders & H…
California Meal and Rest Breaks: What You Don't Know Can Co…
How to Reduce Human Error in a GMP Manufacturing Floor
2-Hour Virtual Seminar on the 6 Most Common Problems in FDA…
Maximizing Productivity with ChatGPT: AI Solutions for HR, …
Excel - Pivot Tables - The Key To Modern Data Analysis and …
Re-imagine Finance & Accounting Made Simple. Three Webinars…
Form W-9 Compliance to Avoid Penalties: TIN Verification, B…
21 CFR Part 11 - Compliance for Electronic Records and Sign…
New EEOC Report: Workplace Harassment Prevention Not Workin…
Transforming Change and Conflict into Diverse-Inclusive-Col…
ChatGPT and Project Management: Leveraging AI for Project M…
Excel Power Skills: Master Functions, Formulas, and Macros …
Construction Lending And Real Credit Administration: Evalua…
Develop People Intelligence: Is Your Communication Style as…